etomidate has been researched along with ACTH Syndrome, Ectopic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Constantinescu, SM; Corvilain, B; Driessens, N; Furnica, RM; Lefebvre, A; Maiter, D | 1 |
Joshiraj, B; Kishore, S; Krishnan, G; Misra, M; Sharma, A; Subramaniam, R; Varma, P | 1 |
Canada, TW; Johnson, TN | 1 |
3 other study(ies) available for etomidate and ACTH Syndrome, Ectopic
Article | Year |
---|---|
Etomidate infusion at low doses is an effective and safe treatment for severe Cushing's syndrome outside intensive care.
Topics: ACTH Syndrome, Ectopic; Adrenal Gland Neoplasms; Adult; Aged; Cushing Syndrome; Dose-Response Relationship, Drug; Etomidate; Female; Hospital Units; Humans; Hydrocortisone; Intensive Care Units; Male; Middle Aged; Treatment Outcome | 2020 |
Anesthetic management of emergent laparoscopic bilateral adrenalectomy in a patient with a life-threatening cortisol crisis.
Topics: ACTH Syndrome, Ectopic; Adrenalectomy; Adrenocorticotropic Hormone; Anesthetics; Critical Illness; Cushing Syndrome; Edema; Etomidate; Fentanyl; Humans; Hydrocortisone; Hypokalemia; Laparoscopy; Male; Middle Aged; Treatment Outcome | 2015 |
Etomidate use for Cushing's syndrome caused by an ectopic adrenocorticotropic hormone-producing tumor.
Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Aged; Cushing Syndrome; Etomidate; Fatal Outcome; Humans; Hydrocortisone; Hypnotics and Sedatives; Injections, Intravenous; Male; Prostatic Neoplasms | 2007 |